baber/WOPTO huggingface dataset:
Patent DE-69418861-T2 (DE)
Inventor: CERF MARTINE
IPC: B29C48/07
Filed: 1994-12-13
Granted: 1999-10-07
Abstract: Multilayered article including a functionalized and vulcanized elastomer adherent by itself to a thermoplastic chosen from polyamides, PBT, mixtures containing polyvinylidene fluoride and ethylene/vinyl alcohol and ethylene/tetrafluoroethylene copolymers.Composite tubular article made up of an outer sheath of vulcanized elastomer adherent to a hydrocarbon-barrier thermoplastic or associated with an inner layer for producing imperviousness.
Patent DE-69419375-T2 (DE)
Inventor: SEGOT EVELYNE
IPC: A61K8/00
Filed: 1994-10-04
Granted: 2000-03-23
Abstract: The composition, which is for the skin, is stable. This composition contains retinol in the solubilised state in an organic solvent which is liquid at room temperature, chosen from the group consisting of:     i) branched-chain C16-C20 aliphatic fatty alcohols, ii) alkoxylated saturated unbranched- or branched-chain C16-C20 fatty alcohols,   iii) diesters of C6-C14 dicarboxylic acids and isopropyl alcohol  and mixtures of the abovementioned solvents. This composition is intended for the treatment of skin complaints, and especially acne.
Patent DE-69421536-T2 (DE)
Inventor: AKIBA TOSHIFUMI
IPC: C07C51/377
Filed: 1994-08-03
Granted: 2000-07-06
Abstract: A convenient process for producing a compound represented by general formula (2) by the catalytic hydrogenolysis of a compound represented by general formula (1) or (3) in the presence of a base, wherein R represents hydrogen or C1-C4 alkyl; and X represents chlorine or bromine. The obtained compound can be used as an intermediate for producing medicines. <CHEM>
Patent DE-69421934-T2 (DE)
Inventor: MACKEN LUK
IPC: G02B6/38
Filed: 1994-09-02
Granted: 2000-06-29
Abstract: An optical fibre break out device which comprises: 1) means for removably securing the device to an optical fibre organizer; 2) a first passage for retaining a larger fibre tube; and 3) one or more second passages for retaining a plurality of smaller fibre tubes such that fibres can pass between the larger tube and each smaller tube without significant light loss.
Patent DE-69423394-T2 (DE)
Inventor: SUGITANI HIROSHI
IPC: B41J2/16
Filed: 1994-07-28
Granted: 2000-08-31
Abstract: An ink jet head includes a substrate on which a plurality of energy generating elements for generating energy utilized to discharge ink are provided, and a wall member joined to the substrate. The wall member has a plurality of flow passage walls which partially define flow passages, and the energy generated by the energy generating element acts through the flow passage so as to act on the ink to discharge the ink. The flow passages are fully defined when the substrate is joined to the wall member. A recessed portion provided in the substrate of the ink jet head is positioned between adjoining energy generating elements. The recessed portion has a bottom surface located at a position which is lower than a position for a heat acting surface of the substrate along which heat is transmitted to the ink. The flow passage walls of the wall member abut the substrate at the bottom surface. Consequently, any pressure wave generated by the energy generating element is not released to an adjacent flow passage, and crosstalk between the adjoining flow passages can be prevented. As a result, an ink jet head exhibiting excellent printing quality can be provided. <IMAGE>
Patent DE-69429671-T2 (DE)
Inventor: CHANEY I
IPC: G05F1/56
Filed: 1994-08-11
Granted: 2002-08-14
Abstract: A switching circuit comprising a first transistor 16H having a first terminal for conducting load current to a load circuit, and a second terminal coupled to receive a first voltage, and an overcurrent circuit 60H coupled between said first terminal of said first transistor and a control terminal of said first transistor, said overcurrent circuit monitoring a current level through said first transistor, wherein when a current level detected by said overcurrent circuit exceeds a predetermined threshold value, said overcurrent circuit turns off said first transistor after a first predetermined period and turns back on said first transistor after a second predetermined period. <IMAGE>
Patent DE-69431832-T2 (DE)
Inventor: NORTH JOHN ROBERT
IPC: A61K47/48
Filed: 1994-03-18
Granted: 2003-04-10
Abstract: This invention describes a novel agent for the targeted control of a mammalian cell activity, in particular the agent is used to control the interaction of particular cell types with their external environment. The agent has applications as a pharmaceutical for the treatment of a variety of disorders. An agent according to the invention comprises three Domains B, T and E linked together in the following manner: Domain B-Domain T-Domain E where Domain B is the Binding Domain which binds the agent to a Binding Site on the cell which undergoes endocytosis to produce an endosome, Domain T is the Translation Domain which translocates the agent (with or without the Binding Site) from within the endosome across the endosomal membrane into the cytosol of the cell, Domain E is the Effector Domain which inhibits the ability of the Recyclable Membrane Vesicles to transport the Integral Membrane Proteins to the surface of the cell.
Patent DE-69432530-T2 (DE)
Inventor: MCBRIDE WILLIAM
IPC: C07F7/22
Filed: 1994-07-21
Granted: 2004-04-08
Abstract: This invention relates to therapeutic reagents and peptides, radiodiagnostic reagents and peptides, and methods for producing label radiodiagnostic agents. Specifically, the invention relates to linear peptide derivatives and analogs of somatostatin, and embodiments of such peptides radiolabeled with a radioisotope, as well as methods and kits for making, radiolabeling and using such peptides for radiodiagnostic and radiotherapeutic purposes. The invention specifically relates to linear peptide derivatives and analogues of somatostatin radiolabeled with technetium-99m and uses thereof as scintigraphic imaging agents. The invention so specifically relates to liner peptide derivatives and analogues of somatostatin radiolabeled with cytotoxic radioisotopes such as rhenium-186 (186Re) and rhenium-188 (188Re) for use as radiotherapeutic agents. Methods and kits for making, radiolabeling and using such peptides diagnostically and therapeutically in a mammalian body are also provide.
Patent DE-69504004-T2 (DE)
Inventor: CASH WEBSTER
IPC: G21K1/06
Filed: 1995-05-11
Granted: 1999-05-27
Abstract: An optical system for x-rays combines at least two spherical or near spherical mirrors for each dimension in grazing incidence orientation to provide the functions of a lens in the x-ray region. To focus x-ray radiation in both the X and the Y dimensions, one of the mirrors focusses the X dimension, a second mirror focusses the Y direction, a third mirror corrects the X dimension by removing comatic aberration and a fourth mirror corrects the Y dimension. Spherical aberration may also be removed for an even better focus. The order of the mirrors is unimportant.
Patent DE-69506454-T2 (DE)
Inventor: FUMALLE CHRISTIAN RENE GEORGES
IPC: E03F5/06
Filed: 1995-02-16
Granted: 1999-07-08
Abstract: The grating fits into a frame (3) set in the rod, and has end bars (4) which are elastically deformable relative to the other bars (1,2) so that the grating is fitted elastically in the frame. The deformable end bar is connected to the remainder of the grating only by its two ends, between which it has a lug to engage with a notch (7) in the frame; it also has two thrust elements (9) which can interact with the frame and the adjacent bar (1) of the grating. The grating can be made with a deformable bar at each end and a series of parallel main bars between them, joined to the end bars by two transverse bars (2).
Patent DE-69510293-T2 (DE)
Inventor: CHECKETTS STANLEY J
IPC: B66F7/04
Filed: 1995-10-16
Granted: 2000-01-05
Abstract: A device for accelerating and decelerating one or more objects by introducing pressurized fluid through an injection valve into the bore of a housing. A piston is slidably mounted in the bore and has a cable attached to one side. The cable travels through an aperture near one end of the housing before passing over a first pulley and then connecting to a carrier which holds the object or objects. The cable is selected to be of a length such that the piston will not exit the open end of the bore, which is opposite to the end near where the aperture is located. This creates the possibility of operating the device in two different modes. In the first mode, the pressure of the introduced gas is insufficient to propel the objects past the side of the first pulley that is opposite to the initial location of the objects. The force of the introduced fluid accelerates the piston away from the end of the bore near the aperture, subsequently decelerates the piston after it has changed direction, and then begins the cycle again. When a greater pressure is utilized, the fluid will accelerate the piston and the objects until they pass the first pulley; then decelerate the objects until they stop beyond the first pulley; subsequently accelerate the objects toward the first pulley, creating a perceived negative gravitational force if the movement is vertical; and then decelerate the objects after they have again passed the first pulley. <IMAGE>
Patent DE-69511691-T2 (DE)
Inventor: GERHARDSON BERNDT
IPC: A01N63/20
Filed: 1995-04-13
Granted: 2000-03-02
Abstract: PCT No. PCT/SE95/00408 Sec. 371 Date Jan. 17, 1997 Sec. 102(e) Date Jan. 17, 1997 PCT Filed Apr. 13, 1995 PCT Pub. No. WO95/28085 PCT Pub. Date Oct. 26, 1995A pure culture of Pseudomonas chlororaphis strain NCIMB 40616 is disclosed. The strain is useful for a biocontrol composition for the control of plant fungal diseases. Further, a culture broth of the strain is disclosed to be useful wherein antipathogenically active metabolites are contained in the culture broth. In addition a method of controlling the plant fungal diseases is disclosed which is carried out by the introduction of an effective dose of the strain into a plant environment infected with fungal diseases. Also carriers and additives are admixed with the strain in order to provide for the composition. The types of pathogenic fungi which may be controlled using the method and composition are of the genera Drechslera, Microdochium, Tilletia or Ustilago.
Patent DE-69522633-T2 (DE)
Inventor: BUXTON CLARK L
IPC: G06F15/78
Filed: 1995-10-12
Granted: 2002-07-04
Abstract: An integrated processor is fabricated on a single monolithic circuit and employs circuitry to accommodate data-intensive, view-intensive and voice-intensive requirements of modern-day PIDs. The integrated processor includes a CPU core, a memory controller, and a variety of peripheral devices to achieve versatility and high performance functionality. The integrated processor consumes less power by provision of a clock control unit including a plurality of phase-locked loops for generating clock signals of differing frequencies to appropriately clock the various subsystems of the integrated processor. The clock signals provided to the various subsystems by the clock control unit are derived from a single crystal oscillator input signal. A power management unit is incorporated within the integrated processor to control the frequency and/or application of certain clock signals to the various subsystems, as well as to control other power management related functions. The pin-count of the integrated processor is finally minimized by allowing the selective multiplexing of certain external pins depending upon the desired functionality of the integrated processor.
Patent DE-69533223-T2 (DE)
Inventor: RUBIN JEFFREY
IPC: A61K35/12
Filed: 1995-04-28
Granted: 2005-07-14
Abstract: A method of inducing the proliferation and/or differentiation of human fetal pancreatic cells entails contacting such cells in primary culture with Hepatocyte Growth Factor/Scatter Factor, thereby inducing a proliferation of  beta -epithelial cells, an increase in the number of  beta -epithelial cells which form islet-like cell clusters, and an increase in insulin production per cell. The method provides increased numbers of functional islet-like cell clusters for transplantation, for example, into Type 1 diabetic patients. The method can be scaled up so as to provide clinically useful numbers of cells for transplantation.
Patent DE-69534166-T2 (DE)
Inventor: WILSON M
IPC: C12N7/00
Filed: 1995-10-27
Granted: 2006-03-09
Abstract: A recombinant adenovirus and a method for producing the virus are provided which utilize a recombinant shuttle vector comprising adenovirus DNA sequence for the 5' and 3' cis-elements necessary for replication and virion encapsidation in the absence of sequence encoding viral genes and a selected minigene linked thereto, and a helper adenovirus comprising sufficient adenovirus gene sequences necessary for a productive viral infection. Desirably the helper gene is crippled by modifications to its 5' packaging sequences, which facilitates purification of the viral particle from the helper virus.
Patent DE-69603423-T2 (DE)
Inventor: RESHETNIKOV IGOR
IPC: B63B35/44
Filed: 1996-09-09
Granted: 1999-12-16
Abstract: The invention provides a floating facility 1 to recover oily residues which are generated during tanker washing in tanker ships, and by thorough cleaning of the residues and enhanced homogeneity and of the mixtures to ensures high environmental safety of the process and a maximum recovery of useful products. The facility comprises a rectifying column 5 for breaking up the oily residues into fractions, located in a process chamber 4. The facility 1 is provided with accumulating tanks 11,12,13,14,15 for lighter fractions, diesel oil and fuel oil, which are arranged in parallel and connected on one side with the column 5 and on the other side with a pressure drop regulator 8. The setting tanks 2 of the facility are provided with oily water separators 3. <IMAGE>
Patent DE-69609602-T2 (DE)
Inventor: TRAXLER PETER
IPC: C07D487/04
Filed: 1996-03-22
Granted: 2001-04-12
Abstract: PCT No. PCT/EP96/01263 Sec. 371 Date Oct. 3, 1997 Sec. 102(e) Date Oct. 3, 1997 PCT Filed Mar. 22, 1996 PCT Pub. No. WO96/31510 PCT Pub. Date Oct. 10, 19964-Amino-1H-pyrazolo[3,4-d]pyrimidine derivatives of formula I wherein the symbols are as defined in claim 1, and intermediates for their manufacture are described. The compounds of formula I inhibit especially the tyrosine kinase activity of the receptor for epidermal growth factor and can be used, for example, in the case of epidermal hyperproliferation (psoriasis) and as anti-tumor agents.
Patent DE-69611895-T2 (DE)
Inventor: DELPY JEAN-MARIE
IPC: E01B31/17
Filed: 1996-12-16
Granted: 2001-09-06
Abstract: The tool consists of a frame which fits over the rail on both sides of the area to be machined. A mobile assembly has rollers to follow the shape of the rail's head. Series of transverse semi-circular guides (18a,18b,18c) for rollers (19a,19b,19c) ensure that the tool's grinding wheel (16c) meets the rail perpendicular to a tangent to its point of contact in any position. The guide rollers are set in a triangular configuration on a roller carrier connected to the grinding wheel. The summit of the triangle is situated on a vertical axis coinciding with that of the tool when the point of contact coincides with the median plane, while its other two points are equidistant from it. The follower roller is connected to the guide roller carrier by a spring to adjust to rails of different sizes.
Patent DE-69633782-T2 (DE)
Inventor: MADDEN NORMAN
IPC: A61B6/00
Filed: 1996-04-19
Granted: 2005-11-03
Abstract: A system and method for diagnostic testing of structures within a body, e.g., organs within the body of a living being, which has been provided with a radioactive imaging agent, e.g., a radiotracer, to cause the structure to produce gamma rays, associated characteristic x rays, and a continuum of Compton-scattered photons. The system includes a radiation receiving device, e.g., a hand-held probe or camera, an associated signal processor, and an analyzer. The radiation receiving device is arranged to be located adjacent the body and the structure for receiving gamma rays and characteristic x rays emitted from the structure and for providing a processed electrical signal representative thereof. The processed electrical signal includes a first portion representing the characteristic x rays received and a second portion representing the gamma rays received. In a preferred embodiment of the invention the signal processor removes the signal corresponding to the Compton-scattered photons from the electrical signal in the region of the full-energy gamma ray and the characteristic x ray. The analyzer is arranged to selectively use the x-ray portion of said processed signal to provide near-field information about the structure, to selectively use both the x-ray and the gamma-ray portions of said processed signal to provide near-field and far-field information about the structure, and to selectively use the gamma-ray portion of said processed signal to provide extended field information about the structure.
Patent DE-69715320-T2 (DE)
Inventor: BAUMANN GEORGE A
IPC: C07K7/23
Filed: 1997-06-16
Granted: 2003-01-02
Abstract: A process for viral inactivation of a solution containing a biologically active protein, wherein the process comprises the steps of 1) contacting the solution with an immobilized ligand under conditions which allow protein to bind to the ligand, 2) subjecting the bound protein to a viral inactivation method under conditions which would result in substantial denaturation of the protein if it were not bound to the ligand, and 3) recovering the protein by washing the immobilized protein under conditions which favor the release of the protein into the solution under conditions in which the recovered protein retains its biological activity. <IMAGE>
Patent DE-69717465-T2 (DE)
Inventor: BURNHAM A
IPC: B29C48/30
Filed: 1997-08-26
Granted: 2003-07-10
Abstract: The present invention relates to a method which comprises the steps of continuously extruding microcellular polymeric material having cells of essentially uniform size of less than about 50 microns average size from a single-phase solution of polymeric material and blowing agent contained in extrusion apparatus (30) including a nucleating pathway (66), the blowing agent present in the solution in an amount less than about 80 percent saturation concentration as determined at the lowest pressure in the system after the point of blowing agent injection (54) prior to the nucleating pathway (66). <IMAGE>
Patent DE-69717992-T2 (DE)
Inventor: BELLUTTI PIERLUIGI
IPC: H01L27/098
Filed: 1997-10-02
Granted: 2003-07-24
Abstract: The production of the device involving performing a first diffusion for obtaining a p-type zone (12) and a subsequent n<+> type diffusion to obtain the gate (16). The depth of this latter diffusion with respect to the preceding one defines the channel zone (20) of the JFET. The doping and thickness of the channel (20) make the JFET structure obtainable directly with CMOS technology avoiding the addition of otherwise necessary photolithographic and implantation steps. <IMAGE>
Patent DE-69723163-T2 (DE)
Inventor: PICARELLI ANTONIO
IPC: C07K14/415
Filed: 1997-07-23
Granted: 2004-05-19
Abstract: In order to diagnose the coeliac disease antiendomysial antibodies are detected through immunofluorescence techniques in culture media in which bioptic fragments of the human enteral mucosa are kept alive. The cultures of the enteral mucosa take place by dipping the bioptic fragment into nutrient liquids with or without the presence of low concentrations of peptic-tryptic digest of gliadin. The peptide fragment of gliadin containing a definite aminoacid sequence capable of production of antiendomysial antibodies to a greater extent than the PT digest, even in very little concentration, is also identified.
Patent DE-69728052-T2 (DE)
Inventor: HISAW JACK C
IPC: E21B34/14
Filed: 1997-11-04
Granted: 2005-02-24
Abstract: A novel venturi device located within a tubular member for accelerating the flow of an effluent is disclosed. The device will generally comprise a tubular member containing a throat section, a diffuser section and an opening contained on the tubular member for allowing the injection of a gas therethrough. The device also includes an inner mandrel contained within the tubular member. The inner mandrel contains a nozzle member defining an internal chamber. The inner mandrel also contains a first passageway and a second passageway for directing the effluent therethrough. The nozzle is operatively associated with the opening contained on the tubular member. In one embodiment, a flow diverter member is included for diverting the production effluent into the first passageway and into the nozzle annulus. A method of accelerating production with a venturi device within a tubing string is also disclosed.
Patent DE-69729439-T2 (DE)
Inventor: LEHTONEN MATTI
IPC: H02H3/16
Filed: 1997-10-03
Granted: 2005-06-09
Abstract: The invention relates to detecting and locating a high-resistance earth fault of an electric power network. In the method, the substation is measured at the neutral point voltage (<u>U</u>o) in phasor format. According to the method, the phase leg voltages of the network are measured in phasor format, the zero-sequence voltage phasor representing the neutral point voltage (<u>U</u>o) is formed as the phasor sum of the measured phase leg voltages, the zero-sequence impedance (<u>Z</u>o) is computed by means of a network model, whereafter the zero-sequence voltage (<u>U</u>o) is compared in phasor format with the phasors of the network phase leg voltages (<u>U</u>v) and the resultant zero-sequence impedance (<u>Z</u>o) of the network, and from these computed variables are derived the fault impedances (<u>Z</u>f) for each phase leg, whereafter the faulted leg is identified as the leg having the greatest value of the real part of the fault impedance (<u>Z</u>f).
Patent DE-69729729-T2 (DE)
Inventor: MAUREL JEAN-CLAUDE
IPC: A61K9/00
Filed: 1997-07-11
Granted: 2005-08-04
Abstract: The invention concerns a pharmaceutical composition to be administered orally with absorption of at least one active principle preferably through the mucous membranes of the mouth, comprising an excipient containing at least one sugar and optionally a texturing agent, characterised in that said excipient further contains one fat or one vegetable or animal oil. The composition constituted a perfectly homogeneous mixture, containing at least 10 % unconnected water, 1 to 15 % fat or oil and 50 to 80 % sugar or sweetening agents. The active principles of the medicines can be brought in solid or liquid form, soluble or insoluble in water or the fats, hygroscopic or not; they can be indifferently absorbed at any level of the digestive tube; however the composition isi advantageously adapted to absorption through the mucous membranes of the mouth. The compositions are in the form of tablets, pastes, lozenges.
Patent DE-69733383-T2 (DE)
Inventor: DUPUIS JEAN CLAUDE FREDERIC
IPC: E01F15/12
Filed: 1997-06-27
Granted: 2006-04-27
Abstract: The safety barrier has a fixed part and a movable part. The safety barrier enables forming a temporary vehicle passage. The fixed part is formed from rails (2b,2c) parallel to the ground fitted to supports (1,3). The supports consist of a vertical post embedded in the ground and rail connecting pieces. The movable part is formed by a leaf constituted by movable rail segments (10,11) articulated about a vertical axis. The movable rail segments are directly connected to the fixed rail segments by vertical pivots (20,30) located behind the rail segments and separated from the support.